Unadjusted analysis | adjusted analysis | |||
---|---|---|---|---|
OR(95% confidence interval) | p | OR(95% confidence interval) | p | |
Age(years) | 1.01(0.96–1.07) | 0.746 | 1.01(0.93–1.10) | 0.831 |
ASA physical status | ||||
1 | 1 | 1 | ||
2 | 0.82(0.27–2.49) | 0.730 | 0.40(0.06–2.49) | 0.324 |
3 | 1.25(0.21–7.41) | 0.806 | 0.37(0.02–7.30) | 0.517 |
Cerebrovascular disease | 2.66(1.28–5.54) | 0.009 | 2.08(0.70–6.18) | 0.188 |
Baseline MAP(mmHg) | 1.02(0.99–1.05) | 0.134 | 1.03(0.99–1.08) | 0.167 |
dAXVmax(cm) | 3.61(0.23–56.49) | 0.361 | 0.20(0.00-14.30) | 0.462 |
AXV-CI(%) | 1.13(1.09–1.18) | < 0.001 | 1.12(1.07–1.18) | < 0.001 |
dIVCmax(cm) | 1.41(0.31–6.43) | 0.656 | 0.79(0.09–6.96) | 0.831 |
IVC-CI(%) | 1.19(1.13–1.24) | < 0.001 | 1.18(1.11–1.25) | < 0.001 |